Session Information
-
NACLC 2019
2019 North American Conference on Lung Cancer
(Chicago, IL, USA): October 10 – 12, 2019
The NACLC 2019 Virtual Meeting will be composed of the PowerPoint slides of the presentations only.Presentation Date(s):- October 10 – 12, 2019
- Total Presentations: 125
-
+
GS02 - Prevention, Early Detection and Patient Provider Partnerships
- 08:05 - 09:45
- 10/11/2019
- Location: Imperial Ballroom (B2 Level)
- IASLC CME Accredited
- Type: Invited Speaker Session
- Track:
-
+
GS02.01 - Welcome and Travel Award Presentations
08:05 - 08:10
- Abstract
No abstract available for this presentation
-
+
GS02.02 - Clinical Trial Shaping Our Next Step - Partnership between Investigators and Patients
08:10 - 08:25 | Presenter: Karen Kelly
- Abstract
No abstract available for this presentation
-
+
GS02.03 - Electronic Cigarettes and Vaping
08:25 - 08:35 | Presenter: Anthony Alberg
- Abstract
No abstract available for this presentation
-
+
GS02.04 - Imaging to Identify and Characterize Lung Nodules
08:35 - 08:50 | Presenter: Herbert MacMahon
- Abstract
No abstract available for this presentation
-
+
GS02.05 - Molecular Biomarkers in Early Detection of Lung Cancer
08:50 - 09:00 | Presenter: Peter Mazzone
- Abstract
No abstract available for this presentation
-
+
GS02.06 - How Lung Cancer Advocacy and Research Has Changed in the Past Years
09:00 - 09:10 | Presenter: Jill Feldman
- Abstract
No abstract available for this presentation
-
+
GS02.07 - The Increasing Importance of Social Media in Advocacy
09:10 - 09:20 | Presenter: Brendon Stiles
- Abstract
No abstract available for this presentation
-
+
GS02.08 - Financial Toxicity of Cancer Therapy
09:20 - 09:30 | Presenter: Fumiko Chino
- Abstract
No abstract available for this presentation
-
+
GS02.09 - Panel Discussion
09:30 - 09:45
- Abstract
No abstract available for this presentation
-
+
GS03 - Biomarkers in 2019 and Beyond
- 10:15 - 11:15
- 10/11/2019
- Location: Imperial Ballroom (B2 Level)
- IASLC CME Accredited
- Type: Invited Speaker Session
- Track:
-
+
GS03.01 - Introduction
10:15 - 10:20 | Presenter: Charu Aggarwal
- Abstract
No abstract available for this presentation
-
+
GS03.02 - Innovations in Broad Sequencing Including Fusion Detection and Cellularity Constraints
10:20 - 10:30 | Presenter: Marc Ladanyi
- Abstract
No abstract available for this presentation
-
+
GS03.03 - TMB Ready for Prime Time?
10:30 - 10:40 | Presenter: John Longshore
- Abstract
No abstract available for this presentation
-
+
GS03.04 - Incorporating Blood Biomarkers into Clinical Practice
10:40 - 10:50 | Presenter: Charu Aggarwal
- Abstract
No abstract available for this presentation
-
+
GS03.05 - Genomic Biomarkers of Immunotherapy Sensitivity and Resistance
10:50 - 11:00 | Presenter: Ferdinandos Skoulidis
- Abstract
No abstract available for this presentation
-
+
GS03.06 - Panel Discussion
11:00 - 11:15
- Abstract
No abstract available for this presentation
-
+
GS04 - Patient Selection for Local Therapies in the Era of Immunotherapy
- 10:15 - 11:15
- 10/11/2019
- Location: Rouge (Lobby Level)
- IASLC CME Accredited
- Type: Invited Speaker Session
- Track:
-
+
GS04.01 - Introduction
10:15 - 10:20 | Presenter: Jessica Donington
- Abstract
No abstract available for this presentation
-
+
GS04.02 - Pre-habilitation/Patient Selection and Enhanced Recovery after Surgery (ERAS)
10:20 - 10:28 | Presenter: Katerine Kuhns
- Abstract
No abstract available for this presentation
-
+
GS04.03 - Induction Strategies for Stage II/IIIA NSCLC including Radiation and IO
10:28 - 10:36 | Presenter: Jessica Donington
- Abstract
No abstract available for this presentation
-
+
GS04.04 - Role of IO and SBRT for Inoperable Early Stage NCLC
10:36 - 10:44 | Presenter: Clifford Robinson
- Abstract
No abstract available for this presentation
-
+
GS04.05 - Recurrence after SBRT
10:44 - 10:52 | Presenter: Mara B. Antonoff
- Abstract
No abstract available for this presentation
-
+
GS04.06 - Assessment and Management of IO Toxicity in Combined Modality Trials
10:52 - 11:00 | Presenter: Mary Fidler
- Abstract
No abstract available for this presentation
-
+
GS04.07 - Panel Discussion
11:00 - 11:15
- Abstract
No abstract available for this presentation
-
+
GS05 - Keynote: NCI Perspectives: Lung Cancer Initiatives
- 12:45 - 13:45
- 10/11/2019
- Location: Imperial Ballroom (B2 Level)
- IASLC CME Accredited
- Type: Invited Speaker Session
- Track:
-
+
GS05.01 - Introduction
12:45 - 12:50 | Presenter: Everett Vokes
- Abstract
No abstract available for this presentation
-
+
GS05.02 - Keynote: NCI Perspectives: Lung Cancer Initiatives
12:50 - 13:35 | Presenter: Douglas Lowy
- Abstract
No abstract available for this presentation
-
+
OA01 - Precision Medicine and Personalized Therapy for Lung Cancer
- 14:00 - 15:40
- 10/11/2019
- Location: Imperial Ballroom (B2 Level)
- IASLC CME Accredited
- Type: Oral Abstract Session
- Track:
-
+
OA01.01 - Pembrolizumab Plus Chemotherapy For Advanced NSCLC Without Tumor PD-L1 Expression: Pooled Analysis of KN021G, KN189 and KN407
15:00 - 15:07 | Presenter: Hossein Borghaei | Author(s): Corey Langer, Luis Paz-Ares, Delvys Rodriguez-Abreu, Vassiliki Papadimitrakopoulou, Marina Garassino, Baerin Houghton, Takayasu Kurata, Ying Cheng, Jianxin Lin, Cetherine Pietanza, Bilal Piperdi, Shirish Gadgeel
- Abstract
Loading... -
+
OA01.02 - Prognostic Value of Baseline Autoantibodies in Metastatic NSCLC Patients Receiving PD-/PDL-1 Targeted Immunotherapy
14:07 - 14:14 | Presenter: Imad Tarhoni | Author(s): Revathi Kollipara, Wen-Rong Li, Hita Moudgalya, Mary Fidler, Marta Batus, Philip Bonomi, Jeffrey Borgia
- Abstract
Loading... -
+
OA01.03 - Prognostic Role of NLR in Stage III NSCLC Undergoing Chemoradiation: Secondary Analysis of PROCLAIM Trial
14:14 - 14:21 | Presenter: tithi biswas | Author(s): Kylie Kang, David Bajor, Afshin Dowlati, Mitchell Machtay, Jimmy Efird
- Abstract
Loading... -
+
OA01.04 - Safety and Efficacy of Flu Vaccination after Treatment with Immune Checkpoint Inhibitors: A Retrospective Review
15:21 - 15:28 | Presenter: Nathan Roberts | Author(s): Andrew Dothard, Tamjeed Ahmed, William Petty, Jimmy Ruiz, Thomas Lycan Jr.
- Abstract
Loading... -
+
OA01.05 - Discussant: IO Prognostics Beyond PD-L1 and TMB
14:00 - 15:40 | Presenter: Nasser Hanna
- Abstract
No abstract available for this presentation
-
+
OA01.06 - Safety, Efficacy, and Pharmacokinetics of AMG 510, a Novel KRASG12C Inhibitor, in Patients with Non-Small Cell Lung Cancer
14:38 - 14:43 | Presenter: Bob Li | Author(s): Ramaswamy Govindan, Marwan Fakih, Timothy Price, Gerald Falchook, Jayesh Desai, James Kuo, John Strickler, John Krauss, Crystal Denlinger, Greg Durm, Jude Ngang, Haby Henary, Gataree Ngarmchamnanrith, Erik Rasmussen, Phuong Khanh Morrow, David Hong
- Abstract
Loading... -
+
OA01.07 - Capmatinib (INC280) in METΔex14-mutated Advanced NSCLC: Efficacy Data from the Phase 2 GEOMETRY Mono-1 Study
15:43 - 15:48 | Presenter: Rebecca S. Heist | Author(s): Juergen Wolf, Takashi Seto, Ji-Youn Han, Noemi Reguart, Harry J. M. Groen, Daniel S. W. Tan, Toyoaki Hida, Maja de Jonge, Sergey V Orlov, Egbert F Smit, Pierre-Jean Souquet, Johan Vansteenkiste, Monica Giovannini, Sylvie Le Mouhaer, Anna Robeva, Maeve Waldron-Lynch, Edward B. Garon
- Abstract
Loading... -
+
OA01.08 - A Phase I Study to Evaluate Safety and Antitumor Activity of BPI-7711 in EGFRm+/T790M+ Advanced or Recurrent NSCLC Patients
14:48 - 14:53 | Presenter: Yuankai Shi | Author(s): Jian Fang, Yongqian Shu, Donglin Wang, Huiqing Yu, Yanqiu Zhao, Liangming Zhang, Bo Zhu, Xingya Li, Gongyan Chen, Jianhua Shi, Rongsheng Zheng, Jian'an Huang, Sheng Yang, Jieran Long, Wen Gao, Michael Greco, Guoqiang Hu, Xiao Li
- Abstract
Loading... -
+
OA01.09 - Discussant
14:53 - 15:03 | Presenter: Jyoti Patel
- Abstract
No abstract available for this presentation
-
+
OA01.10 - Comparing Regional Results from the IASLC Global Survey on Molecular Testing in Lung Cancer
15:03 - 15:13 | Presenter: Matthew Smeltzer | Author(s): Murry Wynes, Sylvie Lantuejoul, Ross A Soo, Liliana Dalurzo, Enriqueta Felip, Gina Hollenbeck, Kristin Howell, Keith Kerr, Edward Kim, Clarissa Mathias, Pieter Postmus, Charles Powell, Suresh Ramalingam, Kristin Richeimer, Meghan Taylor, Masahiro Tsuboi, Marileila Varella-Garcia, Ignacio Wistuba, Kelsey Wood, Giorgio Scagliotti, Fred Hirsch
- Abstract
Loading... -
+
OA01.11 - Discussant: NGS Path Forward with IASLC
15:13 - 15:23 | Author(s): Heather Wakelee
- Abstract
No abstract available for this presentation
-
+
PD01 - Poster Discussion Session
- 15:45 - 16:45
- 10/11/2019
- Location: Imperial Ballroom (B2 Level)
- Type: Poster Discussion Session
- Track:
-
+
PD01.01 - Discussant: Practice Patterns: So Many Choices and Optimal Therapies
15:45 - 15:55 | Author(s): Kurt Oettel
- Abstract
No abstract available for this presentation
-
+
PD01.02 - Oncologists’ Management of Advanced NSCLC: A Simulation-Based Performance Assessment
16:55 - 16:55 | Presenter: Ann Carothers | Author(s): Lori Pender, Sarah Atwood, Haleh Kadkhoda, Donna Topping
- Abstract
Loading... -
+
PD01.03 - Changes in Immune Checkpoints Landscape Associated with TGF-β Induced EMT in Lung Adenocarcinoma
16:55 - 16:55 | Presenter: Hita Moudgalya | Author(s): Imad Tarhoni, David Gerard, Jeffrey Borgia
- Abstract
Loading... -
+
PD01.04 - CANOPY-A: A Phase 3 Study of Canakinumab as Adjuvant Therapy in Patients With Surgically Resected NSCLC
15:55 - 15:55 | Presenter: David R. Spigel | Author(s): Edward B Garon, Andrea Ardizzoni, Fabrice Barlesi, Byoung Chul Cho, Pedro De Marchi, Yasushi Goto, Shun Lu, Luis Paz-Ares, Michael Thomas, Bijoyesh Mookerjee, Mimi Leung, Jason Baum, Zhu Zewen, James Chih-Hsin Yang
- Abstract
Loading... -
+
PD01.05 - CANOPY-1: Phase 3 Study of Canakinumab/Placebo+Pembrolizumab+Platinum-chemotherapy in Untreated Stage IIIB-IV NSCLC Patients
15:55 - 15:55 | Presenter: Bruce E. Johnson | Author(s): Gilberto de Castro, Alastair Greystoke, Ben Solomon, Daniel S. W. Tan, Vanessa Passos, Stephanie Deudon, Anne Laure Louveau, Enriqueta Felip
- Abstract
Loading... -
+
PD01.06 - CANOPY-2: Phase 3 Study of Canakinumab Plus Docetaxel as Second/Third Line Therapy in Locally Advanced/Metastatic NSCLC
15:55 - 15:55 | Presenter: Bijoyesh Mookerjee | Author(s): Vassiliki A. Papadimitrakopoulou, Yasushi Goto, Darren Wan Teck Lim, Isabelle Malet, Zewen Zhu, Martin Reck, Luis Paz-Ares
- Abstract
Loading... -
+
PD01.07 - Discussant: Novel Risk Prediction Strategies
15:55 - 16:05 | Author(s): Joel Neal
- Abstract
No abstract available for this presentation
-
+
PD01.08 - Incidence and Predictors Associated With the Development of Peripheral Neuropathy in Non-small Cell Lung Cancer Patients
17:05 - 17:05 | Presenter: Jerzy Tyczynski | Author(s): Ravi Potluri, Debasish Mazumder, Rohit Tyagi, Eros Papademetriou
- Abstract
Loading... -
+
PD01.09 - Incidence and Predictors Associated with the Development of Pneumonitis in Non-small Cell Lung Cancer Patients.
17:05 - 17:05 | Presenter: Jerzy Tyczynski | Author(s): Ravi Potluri, Rohit Tyagi, Eros Papademetriou, Debasish Mazumder
- Abstract
Loading... -
+
PD01.10 - Diagnostic Non-Invasive Biopsy Can Substitute Conventional Tissue Dependent Procedures in Suspected Cases of Lung Cancer
16:05 - 16:05 | Presenter: Dadasaheb Akolkar | Author(s): Revati Patil, Darshana Patil, Pradip Fulmali, Sanket Patil, Shoeb Patel, Archana Adhav, Pooja Fulmali, Shabista Khan, Anantbhushan Ranade, Ajay Srinivasan, Rajan Datar
- Abstract
Loading... -
+
PD01.11 - Artificial Intelligence Can Detect Lung Cancer from High Resolution Microscopic Images of Conditioned Peripheral Blood
16:05 - 16:05 | Presenter: Dadasaheb Akolkar | Author(s): Revati Patil, Cynthe Sims, Darshana Patil, Pradip Fulmali, Sanket Patil, Shoeb Patel, Archana Adhav, Vineet Datta, Pooja Fulmali, Shabista Khan, Anantbhushan Ranade, Ajay Srinivasan, Rajan Datar
- Abstract
Loading... -
+
PD01.12 - Discussant: Radiation in 2020 and Beyond
16:15 - 16:25 | Author(s): Kenneth Rosenzweig
- Abstract
No abstract available for this presentation
-
+
PD01.14 - Stereotactic Modulating Radiation Therapy (SMRT) for Oligo-Metastatic Non-Small Cell Lung Cancer
16:15 - 16:15 | Presenter: Joseph Kelley | Author(s): Neil Faulkner, Wahid Hanna, Robert E Heidel, J Francis Turner, Kaleb Darrow
- Abstract
Loading... -
+
PD01.15 - Targeting the Chemoradiation Resistance of Lung Cancers With KRAS/TP53 Co-mutations
17:15 - 17:15 | Presenter: Henning Willers | Author(s): Kristin Gurtner, Cyril Benes, Michael Baumann, Mechthild Krause
- Abstract
Loading... -
+
PD01.16 - Raman Spectroscopy and NIR Spectroscopy as Possible Aid in Localisation of Solitary Pulmonary Nodules
17:15 - 17:15 | Presenter: Jiri Votruba | Author(s): Lucie Habartova, Tom
- Abstract
Loading... -
+
PD01.17 - Discussant: Quality Lung Cancer Care
16:15 - 16:25 | Author(s): Tim Kruser
- Abstract
No abstract available for this presentation
-
+
PD01.18 - Successful Implementation of a Free Lung Cancer Screening Program in a Rural Tertiary Care Hospital Setting.
16:25 - 16:25 | Presenter: Michael J. Minarich | Author(s): Mathew Marsee, Leonard Henry, Ashley Hardy, Ebenezer Kio, Walid Hadid, Leroy Weaver, Urs W von Holzen
- Abstract
Loading... -
+
PD01.19 - Beneficial Effect of Antibiotic Use in Patients With Stage IV NSCLC Treated With Immune Checkpoint Inhibitors.
16:25 - 16:25 | Presenter: Chao Huang | Author(s): Fen Wang, Mohammed Al-Jumayli, Kevin D'Rummo, Lei Pei
- Abstract
Loading... -
+
PD01.20 - Lung Cancer Strategist Program: A Novel Care Delivery Model to Improve Timeliness of Diagnosis and Treatment
16:25 - 16:25 | Presenter: William W Phillips | Author(s): Sophie C. Hofferberth, Julee Armitage, Sam Fox, Claire De Forcrand, Paul Catalano, Christopher Lathan, Joel S. Weissman, David D Odell, Yolonda L Colson
- Abstract
Loading... -
+
PD01.21 - Medicaid Outcome Inequalities in Small Cell Lung Cancer
16:25 - 16:25 | Presenter: Stephen Chun | Author(s): Todd Pezzi, David Schwartz, Katherine Pisters, Abdallah Mohamed, James Welsh, Joe Chang, Zhongxing Liao, Saumil Gandhi, Lauren Byers, Bruce Minsky, Stephen Hahn, Clifton Fuller
- Abstract
Loading...
-
+
P1 - Poster Viewing
- 16:45 - 18:00
- 10/11/2019
- Location: Exhibit Hall
- Type: Poster Session
- Track:
-
+
P1.01 - Clinical Application of Plasma miR-34b-3p and miR-302a-5p in the Diagnosis of Non-small Cell Lung Cancer
16:45 - 18:00 | Presenter: yang liu | Author(s): Suhua Zheng, Zhipeng SONG
- Abstract
Loading... -
+
P1.02 - Chemotherapy with VMAT (Volumetric Modulated Arc Therapy) Radiation Therapy for Poor Risk Stage IIIA-C NSCLC Patients
16:45 - 18:00 | Presenter: Yu Zhou | Author(s): Mary Fidler, Marta Batus, Ethan Ritz, George Tolekidis, Philip Bonomi, Gaurav Marwaha
- Abstract
Loading... -
+
P1.03 - Survival Benefit of Surgically Resected Occult N2 (c-N0,1 and p-N2) Non-small-Cell Lung Cancer
16:45 - 18:00 | Presenter: Masahiko Harada | Author(s): Takashi Yamamichi, Toshiyuki Shima, Hirotoshi Horio
- Abstract
Loading... -
+
P1.04 - Combined Effects of HDAC Inhibitor and Metalloproteinase Inhibitor on Invasion and Growth of Non-Small Cell Lung Cancer
16:45 - 18:00 | Presenter: Yu Zhang
- Abstract
Loading... -
+
P1.05 - Clinical Factors Associated with Progression in Previously Treated Patients with Metastatic NSCLC on Anti-PD-1 Therapy
16:45 - 18:00 | Presenter: Megan Randall | Author(s): Revathi Kollipara, Sanjib Basu, Jeffrey Borgia, Marta Batus, Philip Bonomi, Imad Tarhoni, Ibtihaj Fughhi, Mary Fidler
- Abstract
Loading... -
+
P1.06 - An Overview of Lung and Breast Cancer Using the National Cancer Database
17:45 - 19:00 | Presenter: Leigh Deshotels | Author(s): Gerard Chaaya, Takefumi Komiya
- Abstract
Loading... -
+
P1.07 - External Peer Review of the Western New South Wales Lung Cancer Service – A Unique Regional and Rural Australian Experience
16:45 - 18:00 | Presenter: sugamya Mallawathantri | Author(s): Robert Zielinski, Michael Byrom, Ravi Punwani, Kandeepan Thuraisingam, Karanvir Singh, Lauren Bradbury, Tamara Hollman, Rajath Rai, Kim Turley, Charles Prabhakar, Frances Ferguson, Mooreen Macleay, Joel Begnell, Ruth Jones, Naveed Alam, Yaroslav mayorchak, Peter Flynn, Steven Kao, Ee Siang Choong, Mary Duffy, Ricahrd Osborne, Martin Phillips, Kwun Fong, David Baldwin
- Abstract
Loading... -
+
P1.08 - Immunophenotyping of CD 146 Expression T Cells in Lung Cancer Patients
16:45 - 18:00 | Presenter: Ayobami Olajuyin | Author(s): Adefunke Kafayat Olajuyin, Ziqi Wang, Zhingru Zhao, Xiaoju Zhang
- Abstract
Loading... -
+
P1.09 - Circulating Cancer Stem Cell-Derived Extracellular Vesicles as a Novel Biomarker for Clinical Outcome Evaluation in NSCLC
16:45 - 18:00 | Presenter: Davide Brocco | Author(s): Paola Lanuti, Pasquale Simeone, Giuseppina Bologna, Michele De Tursi, Luciana Irtelli, Pietro Di Marino, Marta Peri, Marco Marchisio, Sebastiano Miscia, Nicola Tinari
- Abstract
Loading... -
+
P1.10 - Inflammatory Signature Difference in Rural Urban and Regional Occupational Exposure in Lung Cancer
16:45 - 18:00 | Presenter: Paul Walker | Author(s): Nitika Sharma, Geoffrey Stroud
- Abstract
Loading... -
+
P1.11 - Post-PACIFIC Trial Era: Patterns of Outcomes and Toxicities From a Single Private Institution in a Developing Country
16:45 - 18:00 | Presenter: Daniel Przybysz | Author(s): Fl, Tatiane Montella, Rogerio Rufino, Thiago Mafort, Carlos Gil Ferreira
- Abstract
Loading... -
+
P1.12 - Demographics and Survival in Malignant Pleural Mesothelioma: Analysis of SEER Data
16:45 - 18:00 | Presenter: Nwabundo Anusim | Author(s): Filip Ionescu, Ishmael Jaiyesimi
- Abstract
Loading... -
+
P1.13 - Anaplastic Lymphoma Kinase (ALK) Gene Rearrangement in Children and Young Adults with Mesothelioma
17:45 - 19:00 | Presenter: Idrees Mian | Author(s): Ziad Abdullaev, Betsy Morrow, Shaojian Gao, Markku Mettienen, Jun Wei, Javed Khan, Svetlana Pack, Raffit Hassan
- Abstract
Loading... -
+
P1.14 - Immune Profiling Data and Mutational Status Improves Prediction of Risk of Death in Non-small Cell Lung Carcinoma
16:45 - 18:00 | Presenter: Edwin Parra | Author(s): Mei Jang, Juliana Machado-Rugolo, Cec, Maria Nagai, Tereza Takagaki, Ricardo Terra, Alexandre Fabro, Vera Capelozzi
- Abstract
Loading... -
+
P1.15 - The Presence of Secondary Follicles in Early Stage Lung Adenocarcinoma Reflects Disease Burden.
16:45 - 18:00 | Presenter: Rebecca Obeng | Author(s): Madhusmita Behera, Taofeek Owonikoko, Rathi Pillai, Rafi Ahmed, Suresh Ramalingam, Gabriel Sica
- Abstract
Loading... -
+
P1.16 - A Study on Clinicopathological Features and Diagnostic Methods of ALK Fusion-Positive Non-small Cell Lung Cancer in Korea
16:45 - 18:00 | Presenter: Bong Kyung Shin | Author(s): Won Chul Chang, Han Kyeom Kim
- Abstract
Loading... -
+
P1.17 - Comparison of Genetic Profiles of Pulmonary Sarcomatoid Carcinoma (PSC) Between Asian and Western Populations
16:45 - 18:00 | Presenter: Yijia Guo | Author(s): Xiangyan Zhang, Rui Cao, Li Sun, Letian Huang, Jianzhu Zhao, Jietao Ma, Chengbo Han
- Abstract
Loading... -
+
P1.18 - MERTK Activation Drives Osimertinib Resistance in EGFR-mutated Non-small Cell Lung Cancer
16:45 - 18:00 | Presenter: Dan Yan | Author(s): Justus Huelse, Rebecca Parker, Xiaodong Wang, Stephen Frye, H. Shelton Earp, Deborah DeRyckere, Douglas Graham
- Abstract
Loading... -
+
P1.19 - Lung Cancer Screening Initiative and Identification of Novel Blood Biomarkers for Early Detection of Lung Cancer
16:45 - 18:00 | Presenter: Shreya Deb | Author(s): Adijan Kuckovic, Austin Anderson, Joseph Berei, Shylendra Sreenivasappa, Joseph Ross, Sandra Martell, Connie Vitali, William Schulz, Kavya Sri Racherla, Neelu Puri
- Abstract
Loading... -
+
P1.20 - Metabolic Responses to Metformin in Early-stage NSCLC Treated With Definitive Radiotherapy: Results of a Phase II Trial
16:45 - 18:00 | Presenter: Stephen Chun | Author(s): Zhongxing Liao, Melenda Jeter, Joe Chang, Steven Lin, Ritsuko Komaki, Thomas Guerrero, Ray Mayo, Bobby Korah, Suja Koshy, John Heymach, Albert Koong, Heath Skinner
- Abstract
Loading... -
+
P1.21 - RNA Pathway Enrichment in Serum Based Mass Spectroscopy Prognostic Analyses.
16:45 - 18:00 | Presenter: Mary Fidler | Author(s): Ankur Raqib, Philip Bonomi, Marta Batus, jeffery borgia
- Abstract
Loading... -
+
P1.22 - The Lung Microbiome and Metabolome Are Altered in Lung Cancer Patients.
16:45 - 18:00 | Presenter: Frank Weinberg
- Abstract
Loading...